chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The pt drank a tea with cinnamon in it which she has a known allergy to.  Once she realized this she took two 25mg  Benadryl.  She did not inform us of this until after the shot was given and she was under observation.  As her signs of difficulty breathing and allergic blotches on her face increased 911 was called and an Epipen was used.
Persisted for three days: 3-degree fever Body Aches Chills Feverishness Delirium  Fourth day: Body Aches Chills Vice-like, stabbing migraine on right side--similiar to post herpetic neuralgia
Mom as historian - states patient had a rectal temp of 104 the day of vaccines. Gave TYLENOL, no recurrence. No other sx noted.
This spontaneous report as received from a administrator, concerning a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 15-SEP-2014, the patient was vaccinated with the second dose of GARDASIL (dose, dose number, lot number, expiration date and route were not reported). Co-suspect and concomitant therapies were not reported. The administrator reported that an unspecified patient received dose one of GARDASIL on 09-APR-2008. The administrator reported that this patient received dose two of GARDASIL on 15-SEP-2014. No adverse effects reported. Additional information has been requested.
6:45 pm - Numbness began in right arm, moved down his leg, then to the right side of his face. Paralysis experienced on whole right side. Went to medical center - Diagnosed with stroke transferred to hospital.
This case was reported by a pharmacist via sales rep and described the occurrence of injection site pain in an unspecified number of patients who received HAVRIX. On an unknown date, the patients received HAVRIX. On an unknown date, unknown after receiving HAVRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved. The reporter considered the injection site pain to be related to HAVRIX. Additional details were provided as follows: The age at vaccination was not reported. The pharmacist mentioned that a few people complained of pain at the injection site after receiving the vaccine and it lasted 1 to 2 days and then resolved. The information in this report was all that the reporter had provided.
Puffiness at injection site, redness at injection site, is hot to the touch and itchy
Patient reported rash on chest only after receiving the second vaccine.  It was not painful or itchy just red.
In the area where the shot was administered there was a lump. It was sore to where I was unable to lift arm  but these symptoms were gone by the end of the day. I'm not sure if the fever and chills have anything to do with the vaccine but I was at school. I started feeling tired walking home from the post office. I developed strong chills and my face felt flush. I generally did not feel well at all. I had a telehealth visit with my doctor who stated that I may have had a virus. By that Monday I was ok. I took over the counter medications to treat my sandwich
genital herpes sores; This spontaneous case was reported by a consumer and describes the occurrence of GENITAL HERPES (genital herpes sores) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included Genital herpes. Concomitant products included FAMOTIDINE, CITALOPRAM, LEVOTHYROXINE and ATORVASTATIN for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced GENITAL HERPES (genital herpes sores). In January 2021, GENITAL HERPES (genital herpes sores) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the event included none.   This case was linked to MOD-2021-032016 (Patient Link).
ITP dx on 11MAR93 -1wk purpura;monitored till 18MAR93 then rectal bleeding;rx w/IV gamma globulin in hosp x 2 doses then outpatient monitoring x 5 months while activities limited; mild h/a;
77-year-old male with history of coronary artery disease must CHF brought in from home for worsening shortness of breath, per EMS saturation found to be in the 50s that improved on CPAP, apparently patient received his COVID-19 earlier today. Denies fever, chills, nausea, vomiting, chest pain, abdominal p
Breakthrough positive COVID case (tested positive 8/24/21 after being contacted that a coworker I had been in contact with had tested positive on 8/23/21)
Approximately 35 minutes after administration of vaccine, patient experienced itching on right palm then after a while to the left palm which resolved by taking 25 mg Benadryl
C/O pain in arm where vaccinated. No redness, swelling or heat. Was seen at Urgent Care x 2. Dx with local vaccine reaction.
Post administration, patient was shopping in grocery store and had syncope event, causing him to get light headed and fall back and hit his head.
Injection site started itching as I exited Dr office.  Site was red, hot, swollen and itchy for four days after which I called Dr and was advised to use Benadryl to counter act the allergic reaction..injection site most resembled a gigantic hive...the size of a pancake.  immediate injection site indicated by firm nodule under skin that was tender and itchy.  Today nodule still remains however it is shrinking and no longer tender or itchy.  Welted hive has gone leaving discolored area resembling a bruise.
This spontaneous report as received from a pharmacist refers to his son, a male patient of unknown age. On unknown dates, the patient was vaccinated with first, second and third doses of GARDASIL (dose, route, lot # and expiration date were not provided). On 07-AUG-2015, the patient was inadvertently given a fourth dose of GARDASIL. No adverse experiences were reported. Additional information has been requested.
bad headache; felt lethargic; This is a spontaneous report received from a contactable consumer or other non hcp. A 45-years-old male patient received 1st dose of bnt162b2 (COMIRNATY,Batch/Lot number was not reported), via an unspecified route of administration on Aug2021,at the age of 45 years old, as Dose 1,single for covid-19 immunization.The patient medical history and concomitant medications were not reported.The patient experienced he had bad headache on Aug2021 and felt lethargic on Aug2021.The outcome of the event was recovered.Upon followup received on 26 aug 2021,The patient stated that he took the first shot 3 weeks ago and within 15 mins he got a real bad headache for 3 days with being real lethargic.After second shot of Pfizer vaccine,the headache started 15 to 20 minutes after and he didn't feel right.The patient didn't visit the doctor.His employer said he would get fired if he didn't have a shot. Now he feels terrible and he doesn't know what to do. Response received from DSU end was,6 OVERALL SAFETY SUMMARY In clinical studies, adverse reactions in participants 16 years of age  fatigue (62.9%), headache (55.1%), chills (31.9%), and fever (14.2%). LAB-1457-12.0 Revised: 23 August 2021 Follow-up (26Aug2021): This is a follow-up spontaneous report received from a contactable consumer. This 45-year-old male consumer (patient) reported for himself that Dates for same experience, only worse and the headache start 15 to 20 minutes after was unspecified,He just wants to make someone aware and to see if its normal. His left side of his head down to his neck and face is on fire.Patient wanted to know whether these adverse events are related to the Pfizer covid vaccine.Address, Alternative Telephone, Email address - Caller declined to provide at this time.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
61 y/o male with past medical history of HTN and Hypercholesterolemia, who presents with dizziness onset after vaccination. Patient states that this is his 2nd vaccination in two-dose series. Patient denies reaction to first vaccination, states that he went home and went to sleep. Patient received the vaccination to the Left arm. NP and Paramedics at patient side. Patient placed on cot and placed in Trendelenburg. Patient vitals within normal limits of his medical history (145/95 BP, 77 HR, 14 Resp, 98% RA, Glucose 149). Patient observed for 25 minutes with resolution of symptoms. Patient states that he is going to go to his mothers? house to sleep. Patient cleared to be discharged home.
40 minute generalized seizure 18 hours after vaccines given. No fever. Father administered rectal Diastat 2.5 mg without effect and the paramedics gave 2 mg of IN midazolam. Mother states that the seizure eventually slowed or stopped but re-started en route to the ER, where he was loaded with Keppra. Patient had a 30 minute seizure following vaccines given at 4 months.
Patient has nasal congestion, legs feel achy. Patient shuffled as he walked, generalized "pain". Saw Dr 10-12-06 patient complained of severe constant muscle ache in calves or legs. Patient had difficulty sleeping last night.
Fever, lethargic, increased resting heart, increased breath rate, tachycardia, nausea, and diarrhea.   All symptoms reduced after 50 hours.  3 weeks later- still lethargic.
4 Full doses of the Moderno vaccine; 4 Full doses of the Moderno vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXTRA DOSE ADMINISTERED (4 Full doses of the Moderno vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (4 Full doses of the Moderno vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (4 Full doses of the Moderno vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (4 Full doses of the Moderno vaccine). At the time of the report, EXTRA DOSE ADMINISTERED (4 Full doses of the Moderno vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (4 Full doses of the Moderno vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment information were reported by the reporter
PROVIDER PROGRESS NOTE 2/8/2022 LOS: 7    BRIEF SUMMARY: 76 y.o. male with past medical history of CAD, hypertension, hyperlipidemia, interstitial lung disease and RA on chronic mycophenolate and prednisone who was admitted on 2/1/2022 with shortness of breath, cough, myalgias and malaise, found to have acute hypoxic respiratory failure 2/2 COVID PNA. Rapid escalation of oxygen needs, currently on near maximal support on HFNC; not tolerating BiPAP.   ASSESSMENT/PLAN:  Acute hypoxic respiratory failure likely due to Covid?19 pneumonia Hx interstitial lung disease Symptomatic x1 week.  Fully vaccinated and booster dose but risk factors of immunosuppression on MMF and prednisone. CXR on admission shows multiple bilateral airspace opacities, combination of chronic fibrosis and pneumonia. Pro-Cal not suggestive of superimposed bacterial PNA. D-dimer elevated, so obtained CT angiogram which was negative for PE. Started on dexamethasone 6 mg daily, however escalated to HFNC on 2/4 so switched to methylprednisolone 125 mg IV. Maintaining Spo2, however due to increased WOB, started on BiPAP 02/07, however did not tolerate it well. CXR 02/08 with interval worsening of patchy opacities, no focal consolidation.  - continue steroids                 - dexamethasone 6 mg daily (2/1-2/3)                - methylprednisolone 125 mg IV (2/4-TBD) - Full dose Lovenox for prophylactic anticoagulation - Encourage proning as able  - full barrier precaution - start BiPAP due to increased WOB (2/07)                 - hydroxyzine 25-50 mg PO q6H PRN and ativan 0.5 mg IV q6H PRN for anxiety - furosemide 40 mg IV x 1 - Discussed w/ pharm and ID not candidate Toci/ baracitinib - will discuss with team regarding possible transfer   Hx CAD s/p BMS LAD 2008 NSTMEI Trop negative. No chest pain.  - Resume PTA statin   Dyslipidemia - Continue PTA statin.   Hx of HTN - No scheduled BP meds. BP is appropriate.    Mild AKI, resolved  Cr 1.30 on admission, down-trended to 0.8-0.9. Hx of CKD2 per review of EMR. - Avoid nephrotoxins - BMP qAM   Rheumatoid arthritis - holding PTA mycophenolate and prednisone 10 mg daily  - On IV solumedrol as above    Cerebral aneurysm s/p clipping   Hypothyroidism - PTA levothyroxine 50 mcg daily    BPH - PTA tamsulosin
Not feeling well; Stressed; Checked her blood pressure and it was 150/80/blood pressure went up; Not feeling right; This is a spontaneous report from a contactable nurse. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EN5318, Pfizer NTEC), via an unspecified route of administration on 04Feb2021 as 1st dose at unknown dose, single for covid-19 immunization. Medical history included blood pressure problems. Concomitant medication(s) included vitamin c [ascorbic acid], ibuprofen, zinc. The patient stated she took an Ibuprofen one hour before her first dose of the vaccine on 04Feb2021 before and she didn't know before but now it is everywhere that you are not supposed to take Ibuprofen or pain medication and she didn't know but she took. She stated she is worried it might lower the effectiveness of the vaccine. She stated she also took Vitamin C and a whole bunch of immune boosters like Zinc and supplements and asked will the vaccine be less effective. Patient further stated she has high blood pressure. She received the first dose of the vaccine on 04Feb2021, 30 minutes after the shot she was not feeling well and they checked her blood pressure and it was 150/80. When she left she was not feeling bad so she wanted to stop by the grocery store. When she was in the parking lot of the grocery store she was not feeling right (she stated this was a half an hour later) and her blood pressure went up in 04Feb2021. She stated she has blood pressure problems so she may have been stressed out because there were a lot of people there. She took her PRN blood pressure medication, Clonidine, and this usually makes her blood pressure go down in 20 minutes. She waited half an hour but it did not go down. She stated she may have been stressed because it went unusually high. It was better after going home and getting a warm drink. The outcome of the event Blood pressure high, Stress was recovering; other events was unknown.  Follow-up attempts completed. No further information expected.
Patient reported fever, chills and tremor starting approximately 4 and 1/2 hours after the flu shot and lasted for 2 days. Starting 3 days after shot(Sunday night) pt started itching and today(Monday) reports a rash and hives on wrists, arms, shoulder and chest.
Next morning her blood pressure was low, at 100/52; Blood pressure was high, at 169/92; This case was reported by a consumer via call center representative and described the occurrence of blood pressure high in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th September 2019, the patient received the 1st dose of Shingrix. On 27th September 2019, 1 days after receiving Shingrix, the patient experienced blood pressure high. On 28th September 2019, the patient experienced low blood pressure. On an unknown date, the outcome of the blood pressure high and low blood pressure were recovered/resolved.   It was unknown if the reporter considered the blood pressure high and low blood pressure to be related to Shingrix.  Additional details were provided as follows: The patient was fine for a day or so, but then she took her blood pressure and it was high, at 169/92 mmHg. The patient went to bed. In the morning, 2 days after receiving Shingrix, the patient's blood pressure was low, at 100/52 mmHg. Later her blood pressure went back to normal.  The patient's blood pressure usually runs around 120/78 mmHg. The reporter consented to follow up. This case was related to patient.
Developed neuropathy one week post injection with sensation of left side "phantom drooling" sensation.   Developed sensation of liquid running down the left side of chin and subsequent frequent need to wipe at area with fingers but would find no moisture on exam of fingers.  Almost constant sensation for several days then became more intermittent or patient became habituated to the symptoms.   Within 10-14 days, also developed burning sensation on  center of chin.  Saw a neurologist for opinion 2 months into symptoms.  Multiple sclerosis and other neurological disorders ruled out.  Under over the counter supplement therapy at recommendation of neurologist.  Symptoms resolved after total duration of 5 months.
Redness at site of injection about 4 inches in diameter.  Warm to the touch and itchy. Painful to touch.
arm pain, numbness and tingling in both arms, metallic taste in mouth, HA, dry cough, fatigue, chills, malaise, diaphoresis
This spontaneous report as received from a treating pharmacist via a company representative refers to multiple, unspecified patients, during the past three days, had received ZOSTAVAX (Lot# unspecified) single dose injection (dose and location unspecified), and returned to the pharmacy within three days post-vaccination, with symptoms of "cellulitis" at the injection site and surrounding areas. The patient did not reintroduce the therapy, the patient had sought medical attention via contacted pharmacist. At the time of report, the outcome of the event was unknown. Follow up information has been received from a pharmacy manager refers to a 70 year old female patient. On 13-MAY-2013 the patient was vaccinated with a dose of ZOSTAVAX (lot # H019998, no expiration date available) (dose and route not reported). The pharmacy manager confirmed that the adverse event of injection cellulitis did occur 3 days after receiving the vaccination approximately on 16-MAY-2013. Treatment: Primary care physician prescribed KEFLEX to the patient, Pharmacy manager stated that this patient recovered and did not need to be admitted to a hospital for further treatment. This is one of several reports received from the same reporter. It was linked to MARRS# 1312USA010651, and MARRS#1401USA005669. Additional information has been requested.
PATIENT WAS MISTAKENLY GIVEN PFIZER FOR HIS SECOND DOSE INSTEAD OF MODERNA. NO ADVERSE EFFECTS REPORTED
pt recvd vax vax & w/in 24hrs exp fever, chills, & diarrhea;
Feverish, nausea, soreness at injection site, fatigue, achy all over.
It was reported that a 2 month old female patient received an IPOL, an ActHIB, a Tripedia and a Prevnar (Lederle) vaccination on on 03/26/01. Reportedly that same day, the patient developed a local reaction of swelling. Patient became irritable for 6 -7 hours. A physician evaluated the patient. patient treated with compresses and Tylenol. The patient was re-evaluated the next day by physician. patient's condition improved as reported by doctor.
Administered COVID-19 Moderna vaccine to patient. Patient immediately fainted for about 15 seconds, then woke up and began immediately shaking entire body and gripping fists tightly. Both pharmacist and person accompanying patient called 911. Patient was awake and sitting down while 911 was on the way. While waiting for 911 to arrive, patient vomited into a bucket. Emergency medical services then arrived and took patient out on a stretcher.
Pentacel dose was inadvertently given to an 11 year old patient instead of Tdap.  She developed right arm tenderness and was seen again 2 days later and was prescribed Tylenol and advised to use ice packs
Pt. c/o dizziness, nausea. Pt. monitored and released after symptoms subsided.
At night on the day of the vaccine I started with a headache, a dull headache, nothing sharp, really tired and my body was achy. My left arm was sore.  The next day roughly the same symptoms throughout the day, really tired and just kinda achy. On a Holiday after I had the vaccine, when I took the ibuprofen, my husband realized he lost his sense f taste and smell and he realized he was the same way the day before. He got tested Saturday the day after the Holiday and since I was still achy on Saturday I called employee health and they told me to get tested. I was tested through Employee Health ( employee only testing site). I still get tired really quick, I get winded really quickly even after doing chores at the house, like laundry and even if I am sitting still, I still sometimes am short of breath. The dull headaches are still present. I had lost my sense of taste and smell but those came back.
Swollen his eyes; He can't breathe; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: EYE SWELLING (non-serious), outcome "unknown", described as "Swollen his eyes"; DYSPNOEA (non-serious), outcome "unknown", described as "He can't breathe".  Additional information: Reporter just called because their grandson, he had a reaction to the Pfizer vaccine, and they asked for email to send some paper to let you know what happened with their grandson and they sent reporter some paper and they took it to the doctor but they lost the paper. So, they want to see if you can send the paper again. He had reaction, when they put the vaccine, he had swollen his eyes (voice not clear), he can't breathe, they told him, the doctor said that he cannot, they cannot put the vaccine again. The only thing reporter need is the paper they send them to take that paper to the doctor. They took that paper to the doctor, and they lost that. So, reporter calling to see if you can send back that paper. Reporter asked So, where they could get this, where they could send them.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a licensed practice nurse referring to an unspecified patient of unknown age and gender. On an unknown date, the patient was vaccinated with an improperly stored dose of MMR II (dose, frequency, route and lot number not provided). No adverse events were reported. Additional information has been requested.
Patient received her vaccine and walked out to the waiting room. Approximately 2 minutes after receiving vaccine, patient became unresponsive and appeared as though she had "passed out." Patient was lowered to the floor by this nurse. Patient became responsive within seconds of the beginning of the episode and started crying and yelling, stating it was difficult for her to see.  Breathing remained even and unlabored (outside of screaming). Blood pressure taken and was within normal limits. Patient then became unresponsive again and bilateral arms drew up to her chest. 911 was called at this time and paramedics were in the building within minutes. Patient was responsive, sitting up, drinking water, and eating a cracker when paramedics arrived. EMS placed a pulse oximeter on patient, pulse and O2 sat within normal limits. While paramedics were there, patient had another episode of becoming unresponsive and arms drawing up to her chest. Patient's heart rate dropped to the mid-low 40's during this episode. EMS then assisted patient onto the stretcher and took her to the ambulance for additional testing.